Pharmacokinetic Parameters of Oral Firocoxib, Oral Meloxicam, and Transdermal Flunixin in Meat Type Goats
Related Experiment Video
Updated: Jan 9, 2026

Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
Published on: December 14, 2021
Mikaela M Weeder1, Michael D Kleinhenz2, Christopher T Culbertson3
1Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, USA.
Abstract:
The objective of this study was to determine and compare the pharmacokinetics of oral firocoxib, oral meloxicam, and transdermal flunixin (TD) in 44 adult, male castrated, crossbred goats. Pharmacokinetic (PK) analysis was performed for each goat in each phase using non-compartmental methods with descriptive statistics reported. Mean plasma half-life (T1/2 (h)) for oral (PO) administration of firocoxib at varying dosages in meat type castrated goats was reported at 0.5 mg/kg, 1.0 mg/kg, and 2.0 mg/kg at 9.1 (range 6.9-13.4), 10.2 (range 6.4-14.7) and 9.2 (range 6.8-12.8), respectively. For oral meloxicam, mean plasma T1/2 at doses of 1.0 mg/kg, 2.0 mg/kg, and 3.0 mg/kg were 13.3 (range: 10.1-22.3), 13.1 (range: 12-24), and 11.7 (range: 8.3-20.5) hours, respectively. Transdermal flunixin showed mean plasma T1/2 of 16.5 (range: 10.7-62) at 3.3 mg/kg, 22.0 (range: 16.6-67.4) at 4.2 mg/kg, and 17.8 (range: 7.4-56.3) at 5.0 mg/kg. These results highlight significant variability in drug disposition and suggest that further research is warranted to optimize dosing regimens for oral firocoxib, oral meloxicam, and transdermal flunixin in goats.
More Related Videos
12:06Isolation, Expansion, and Differentiation of Mesenchymal Stem Cells from the Infrapatellar Fat Pad of the Goat Stifle Joint
Published on: August 2, 2022
12:18In Vivo Methods to Assess Retinal Ganglion Cell and Optic Nerve Function and Structure in Large Animals
Published on: February 26, 2022
Related Concept Videos
Dosage Regimens: Partial Pharmacokinetic Parameters
Measurement of Bioavailability: Pharmacokinetic Methods
Measurement of Bioavailability: Pharmacodynamic Methods
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
Factors Influencing Drug Absorption: Anatomical Parameters
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry